The Cardiovascular Institute at Florida Hospital Orlando is the first hospital in Central Florida to implant the Impella RP™, the only right sided percutaneous (through the skin) assist device on the market, to treat right-sided heart failure.
The Impella RP is part of the Impella platform which includes the World’s Smallest Heart Pump manufactured by Abiomed. The unique device addresses an unmet need of treating patients who develop acute right heart failure or decompensation following left ventricular assist device implantation, myocardial infarction, heart transplant, or open-heart surgery.
The Impella RP System is indicated for providing circulatory assistance for up to 14 days in pediatric or adult patients with a body surface area ≥ 1.5 m2 who develop acute right heart failure or decompensation following left ventricular assist device implantation, myocardial infarction, heart transplant, or open-heart surgery.
The device does not require an open surgical procedure for insertion, and it can provide up to four liters per minute of hemodynamic support. The Impella RP catheter delivers blood from the inlet area, which sits in the inferior vena cava, through the cannula to the outlet opening near the tip of the catheter in the pulmonary artery.
Traditional treatments for right ventricular issues are limited. Many patients who experience right-sided heart dysfunction have exhausted interventional options and require invasive surgery but are at high risk for complications.
Florida Hospitals’ multidisciplinary team — including Rajesh Shah MD, Scott Silvestry MD and Donald Botta MD — led a collaborative heart team in the catheterization lab during the first implantation at Florida Hospital.
For the first time in history we have the ability to percutaneously support the right ventricle. Previous techniques involved either a version of total cardiopulmonary bypass (ECMO) or surgical RVAD. The the impella RP revolutionizes the support of the right ventricle in such cases as myocardial infarction and post heart surgery right ventricular failure. We are privileged to be able to offer this therapy here at Florida Hospital Orlando for patients –
Scott Silvestry MD-Surgical Director of Thoracic Transplant
Our community of patients and partners deserve the best therapies available. This powerful new addition to our catheterization lab and surgery suite provides an entirely new benefit enabling our staff to treat high-risk patients with right-side heart failure minimally invasively,” said Rajesh Shah MD, ACS Medical Director, Florida Hospital Orlando.
By Rajesh A. Shah, MD and Scott Silvestry MD
Rajesh A. Shah, MD, FACC- ACS is Program Medical Director at Florida Hospital Orlando
specializing in Interventional Cardiology and Advanced Heart Failure Therapies. Dr. Shah also has an integral role within the Heart Transplant program. He is Board Certified Cardiovascular Disease, Interventional Cardiology and Nuclear Medicine. Dr Shah practices at Orlando Cardiac and Vascular Specialists, 251 Maitland Ave. Suite 116, Altamonte Springs, FL 32701. He may be contacted by calling (407) 915.5643
Scott Silvestry, MD,- Surgical Director of Thoracic Transplant, Florida Hospital Orlando
Dr. Silvestry joins the Florida Hospital Transplant Institute from Washington University School of Medicine, where he served as associate professor and the surgical director of the cardiac transplantation and ventricular assist division of cardiothoracic surgery. He has extensive research and publication experience in advanced heart failure, heart transplantation and cardiac disease. Dr. Silvestry received his medical degree from the University of Pennsylvania. He completed both his cardiovascular and thoracic surgery fellowship and cardiac transplantation and ventricular assistance advanced fellowship at Duke University in Durham, North Carolina.
The Florida Hospital Transplant Institute is located at 2415 North Orange Avenue, Suite 700 Orlando, FL 32804, (407) 303-2474, (866) 913-7851